Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Optimal Dose of Prophylactic Naloxone for Opioid-Induced Side Effects in Children
NCT00330343Phase 2Completed
- Sponsor
- Johns Hopkins University
- Start
- May 2004
- Primary completion
- Jun 2009
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 2 trial of naloxone in nausea ((none)), pruritus, Vomiting, sponsored by Johns Hopkins University. Started May 2004; status: completed.
02
Drugs
naloxone
03
Conditions
nausea ((none))pruritusVomiting
Beyond the preview
Go deeper on NCT00330343.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00330343.